News | May 05, 2023
India is emerging as a favourable destination to conduct clinical trials: PwC-USAIC Report
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Specialty Chemicals grew 38% YoY for FY23
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Subscribe To Our Newsletter & Stay Updated
